Goldman Sachs Analyst: Internal Report
(ANTIMEDIA) — One of the most reviled companies in the United States recently gave Americans yet another reason to distrust their power: A recent #Goldman_Sachs report reveals the company questioning whether or not curing chronic illness is compatible with a sustainable business model.
In an internal report viewed by CNBC about the potential of the #biotech_industry and #gene_therapy titled “The Genome Revolution,” analysts asked: “Is curing patients a sustainable business model?” Continue reading “Curing Patients Not a Sustainable Medical Business Model”
0